ImmuneOnco Biopharmaceuticals (Shanghai) Inc. (HKG:1541)
Hong Kong · Delayed Price · Currency is HKD 3.740
+0.180 (5.06%)
Jun 18, 2026, 11:28 AM HKT
ImmuneOnco Biopharmaceuticals (Shanghai) Employees
ImmuneOnco Biopharmaceuticals (Shanghai) had 202 employees as of December 31, 2025. The number of employees increased by 46 or 29.49% compared to the previous year.
Employees
202
Change
46
Growth
29.49%
Revenue / Employee
850.00K HKD
Profits / Employee
-1.20M HKD
Market Cap
1.54B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 202 | 46 | 29.49% | 201 | 1 |
| Jun 30, 2025 | 195 | - | - | 195 | 0 |
| Dec 31, 2024 | 156 | 11 | 7.59% | 156 | 0 |
| Dec 31, 2023 | 145 | - | - | 145 | 0 |
Related Stocks
| Company Name | Employees |
|---|---|
| Hangzhou Jiuyuan Genetic Biopharmaceutical | 1,794 |
| Frontage Holdings | 1,523 |
| Mabpharm | 389 |
| Cutia Therapeutics | 304 |
| Zhaoke Ophthalmology | 276 |
| Clover Biopharmaceuticals | 257 |
| Beijing Biostar Pharmaceuticals | 134 |
| Kintor Pharmaceutical | 123 |